Ny undersøkelse: Folk vil ha mer moderne kreftbehandlinger
Les om resultatene fra Kantar helsepolitiske barometer 2022.
Wenche Gerhardsen is Head of Communications at Oslo Cancer Cluster and Oslo Cancer Cluster Incubator. You can reach her at wg@oslocancercluster.no
Les om resultatene fra Kantar helsepolitiske barometer 2022.
It is a collaboration to tighten the ties between cancer research and information technology.
Marine Jeanmougin is the new EU advisor in Oslo Cancer Cluster. She defines herself as truly European.
Rebekka Rolfsnes is doing her PhD with the start-up AdjuTec Pharma AS and the Department of Pharmacy at the University of Oslo (UiO). Together, they will look for solutions to antibiotic resistance.
Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines.
We are a national non-profit member organization with about 90 members. Our members are Norwegian and international companies, research and financial institutions, university hospitals and organizations – all working in the cancer field.